ALPP and gonorrhea: Considering that our EV-CATCHER assay allows for the purification of intact, functional EVs [81], we propose that PLAP+ EVs purified from maternal plasma from both percreta and previa pregnancies may be tested to treat cells in vitro in order to identify the putative molecular pathways involved in PAS.